戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 osomes containing only the fusion protein (F-virosomes).
2 ic, reconstituted influenza virus envelopes (virosomes).
3 g cause for the formation of lacy or curdled virosomes.
4 scents that appear to adhere only loosely to virosomes.
5 ive than liposomal LPS or fusion-inactivated virosomes.
6 A17, small vesicles form a corona around the virosomes.
7  structures appeared to revert to functional virosomes after a temperature shift to permissive condit
8        In the absence of A14, electron-dense virosomes and distinct clusters of small vesicles accumu
9                   It is a major component of virosomes and has been implicated in viral transcription
10 ertheless, the established safety profile of virosomes and their flexibility with regard to antigen d
11 empty "crescents" that fail to contact these virosomes, and, most strikingly, large numbers of aberra
12        Reconstituted Sendai viral envelopes (virosomes) are well recognized for their promising poten
13 lthough safe and immunogenic, the first such virosome-based malaria vaccine showed no protection in a
14                          Inactivation of the virosomes by low pH pretreatment reduced the potency of
15 n the membrane of hepatocyte-specific Sendai virosomes containing only the fusion protein (F-virosome
16 ivation results in the accumulation of large virosomes, detached membrane crescents, and empty immatu
17 s characterized by the accumulation of large virosomes, empty "crescents" that fail to contact these
18 e suggest an essential role for H5 in normal virosome formation and the initiation of virion morphoge
19 membrane, the majority (80%) of the prebound virosomes had fused with the cells, compared with about
20 m and limited proteolysis experiments with F-virosomes indicated that the presence of L(H) leads to c
21 o analyze hepatic cells in early response to virosome-induced membrane fusion.
22 d gene transfer techniques such as liposome, virosomes, microsphere and nanoparticles.
23 is A - are registered for human use, and the virosome platform is being evaluated as the carrier for
24 l penetrating peptide containing systems and virosomes that can specifically increase the CTL respons
25 ic and lipid-based nanoparticles, liposomes, virosomes, virus-like particles, dendrimers and the like
26 Salmonella minnesota rough-LPS inserted into virosomes was at least 10-fold more potent than free LPS
27 ore potent than free LPS, both when prebound virosomes were allowed to be taken up by the cells at ne
28                     Nonfunctional, "curdled" virosomes were detected in tsH5-4 infections at the nonp
29 n up by the cells at neutral pH and when the virosomes were fused into the plasma membrane by low pH
30 ppear at the periphery of the electron-dense virosomes, with the accumulated vesicles likely contribu

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。